JP2010539188A5 - - Google Patents

Download PDF

Info

Publication number
JP2010539188A5
JP2010539188A5 JP2010525104A JP2010525104A JP2010539188A5 JP 2010539188 A5 JP2010539188 A5 JP 2010539188A5 JP 2010525104 A JP2010525104 A JP 2010525104A JP 2010525104 A JP2010525104 A JP 2010525104A JP 2010539188 A5 JP2010539188 A5 JP 2010539188A5
Authority
JP
Japan
Prior art keywords
group
phenyl
tert
butyl
dioxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010525104A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539188A (ja
JP5726527B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/076594 external-priority patent/WO2009039135A1/en
Publication of JP2010539188A publication Critical patent/JP2010539188A/ja
Publication of JP2010539188A5 publication Critical patent/JP2010539188A5/ja
Application granted granted Critical
Publication of JP5726527B2 publication Critical patent/JP5726527B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010525104A 2007-09-17 2008-09-17 C型肝炎ウイルス(hcv)阻害薬として有用なn−フェニル−ジオキソ−ヒドロピリミジン Active JP5726527B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US97288707P 2007-09-17 2007-09-17
US60/972,887 2007-09-17
US9679408P 2008-09-13 2008-09-13
US61/096,794 2008-09-13
PCT/US2008/076594 WO2009039135A1 (en) 2007-09-17 2008-09-17 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors

Publications (3)

Publication Number Publication Date
JP2010539188A JP2010539188A (ja) 2010-12-16
JP2010539188A5 true JP2010539188A5 (https=) 2012-11-15
JP5726527B2 JP5726527B2 (ja) 2015-06-03

Family

ID=40091991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010525104A Active JP5726527B2 (ja) 2007-09-17 2008-09-17 C型肝炎ウイルス(hcv)阻害薬として有用なn−フェニル−ジオキソ−ヒドロピリミジン

Country Status (14)

Country Link
US (2) US8178548B2 (https=)
EP (3) EP2377854A1 (https=)
JP (1) JP5726527B2 (https=)
CN (3) CN101918369B (https=)
AT (1) ATE512954T1 (https=)
CA (1) CA2699989C (https=)
DK (1) DK2203430T3 (https=)
HR (1) HRP20110632T1 (https=)
MX (1) MX2010002904A (https=)
PL (1) PL2203430T3 (https=)
PT (1) PT2203430E (https=)
RU (1) RU2542099C2 (https=)
WO (1) WO2009039135A1 (https=)
ZA (1) ZA201002690B (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2368882T1 (sl) 2007-09-17 2015-02-27 Abbvie Bahamas Ltd. Antiinfekcijski pirimidini in njihove uporabe
MY162760A (en) * 2007-09-17 2017-07-14 Abbvie Bahamas Ltd Anti-infective agents and uses thereof
DK2203430T3 (da) * 2007-09-17 2011-09-26 Abbott Lab N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
PE20110409A1 (es) 2008-07-23 2011-06-22 Hoffmann La Roche Compuestos heterociclicos antiviricos
CN102164909A (zh) 2008-09-26 2011-08-24 弗·哈夫曼-拉罗切有限公司 用于治疗hcv的吡啶或吡嗪衍生物
CA2741325A1 (en) 2008-10-30 2010-05-06 F. Hoffmann-La Roche Ag Heterocyclic antiviral arylpyridone derivatives
EP2379534A1 (en) 2008-12-22 2011-10-26 F. Hoffmann-La Roche AG Heterocyclic antiviral compounds
SG174252A1 (en) 2009-03-06 2011-10-28 Hoffmann La Roche Heterocyclic antiviral compounds
BRPI1009854A2 (pt) * 2009-03-24 2015-08-25 Abbott Lab Processo para preparar composto antiviral
KR20120011880A (ko) * 2009-04-25 2012-02-08 에프. 호프만-라 로슈 아게 헤테로사이클릭 항바이러스성 화합물
TWI428332B (zh) 2009-06-09 2014-03-01 Hoffmann La Roche 雜環抗病毒化合物
BRPI1011744A2 (pt) * 2009-06-24 2016-03-22 Hoffmann La Roche composto antiviral heterocíclico.
AU2010297290A1 (en) 2009-09-21 2012-03-15 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
EA201200650A1 (ru) 2009-10-30 2012-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Курсы комбинированного лечения вируса гепатита с, включающие bi201335, интерферон-альфа и рибавирин
WO2011061243A1 (en) * 2009-11-21 2011-05-26 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
AU2010333656B2 (en) * 2009-12-18 2015-08-27 Boehringer Ingelheim International Gmbh HCV combination therapy
US9216952B2 (en) 2010-03-23 2015-12-22 Abbvie Inc. Process for preparing antiviral compound
JP5651239B2 (ja) * 2010-07-07 2015-01-07 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 複素環式抗ウイルス化合物
US8895737B2 (en) 2010-07-16 2014-11-25 Shashank Shekhar Process for preparing antiviral compounds
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
BR112013001138A2 (pt) 2010-07-16 2016-07-05 Abbvie Inc ligantes de fosfina para reações catalíticas
CA2829768A1 (en) * 2011-03-18 2012-09-27 Abbvie Inc. Formulations of phenyl uracil compounds
US8989328B2 (en) * 2013-03-14 2015-03-24 Qualcomm Incorporated Systems and methods for serial communication
SI3043803T1 (sl) 2013-09-11 2022-09-30 Emory University Nukleotidne in nukleozidne sestave in njihova uporaba
WO2015197028A1 (en) * 2014-06-28 2015-12-30 Sunshine Lake Pharma Co., Ltd. Compounds as hepatitis c virus (hcv) inhibitors and uses thereof in medicine
EA201892448A1 (ru) 2016-04-28 2019-06-28 Эмори Юниверсити Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения
WO2018085170A1 (en) * 2016-11-01 2018-05-11 Merck Sharp & Dohme Corp. Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors
EP3774804A1 (en) 2018-03-26 2021-02-17 Novartis AG N-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide derivatives
CN110483496B (zh) * 2019-07-17 2021-05-04 杭州市西溪医院 一类具有尿嘧啶-苯并噻唑结构衍生物、其制备方法及抗hcv药物的应用
JP7785663B2 (ja) * 2019-09-16 2025-12-15 ノバルティス アーゲー 二機能性分解誘導薬及びそれらの使用方法
WO2021055348A1 (en) 2019-09-16 2021-03-25 Visa International Service Association System, method, and computer program product for verifying a card image
EP3819006A1 (en) 2019-11-05 2021-05-12 Technische Universität Dresden Compounds with thymine skeleton for use in medicine
CN111018910A (zh) * 2019-12-05 2020-04-17 上海应用技术大学 一种铜催化合成含芳环α-羟基膦酸酯的方法
CN111518036A (zh) * 2020-04-29 2020-08-11 杭州勇诚睿生物科技有限公司 一种达沙布韦关键中间体的制备方法
US12274700B1 (en) 2020-10-30 2025-04-15 Accencio LLC Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239888A (en) * 1974-11-04 1980-12-16 Pfizer Inc. 1-Phenyluracils
JPS60243017A (ja) * 1984-05-16 1985-12-03 Kyowa Hakko Kogyo Co Ltd 抗けいれん組成物
US5084084A (en) * 1989-07-14 1992-01-28 Nissan Chemical Industries Ltd. Uracil derivatives and herbicides containing the same as active ingredient
AU627906B2 (en) * 1989-07-14 1992-09-03 Nissan Chemical Industries Ltd. Uracil derivatives and herbicides containing the same as active ingredient
US5162326A (en) * 1990-02-15 1992-11-10 Takeda Chemical Industries, Ltd. Pyrimidinedione derivatives, their production and use
NL9001075A (https=) * 1990-05-04 1991-12-02 Duphar Int Res
EP0489480A1 (en) * 1990-12-05 1992-06-10 Nissan Chemical Industries Ltd. Uracil derivatives and herbicides containing the same as active ingredient
JPH05213755A (ja) 1992-02-07 1993-08-24 Nikko Kyodo Co Ltd 肝臓障害治療薬
DE19528305A1 (de) 1995-08-02 1997-02-06 Bayer Ag Substituierte Phenyluracile
PL207160B1 (pl) 1999-12-06 2010-11-30 Hoffmann La Roche Pochodne 4-pirymidynylo-N-acylo-L-fenyloalaniny, związki pośrednie, środek farmaceutyczny i ich zastosowanie
US6380387B1 (en) * 1999-12-06 2002-04-30 Hoffmann-La Roche Inc. 4-Pyrimidinyl-n-acyl-l phenylalanines
RU2264395C2 (ru) * 2000-02-04 2005-11-20 Сумитомо Кемикал Компани, Лимитед Производные урацила, гербицидная композиция, способ борьбы с сорняками и промежуточные продукты (варианты)
IL167954A (en) * 2000-02-04 2007-10-31 Sumitomo Chemical Co History of pyrimidine
MY164523A (en) * 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
KR100589964B1 (ko) * 2003-06-13 2006-06-19 주식회사 엘지생명과학 C형 간염 바이러스의 억제제
US7163937B2 (en) 2003-08-21 2007-01-16 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
SI2368882T1 (sl) 2007-09-17 2015-02-27 Abbvie Bahamas Ltd. Antiinfekcijski pirimidini in njihove uporabe
DK2203430T3 (da) 2007-09-17 2011-09-26 Abbott Lab N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
MY162760A (en) * 2007-09-17 2017-07-14 Abbvie Bahamas Ltd Anti-infective agents and uses thereof
PE20110409A1 (es) 2008-07-23 2011-06-22 Hoffmann La Roche Compuestos heterociclicos antiviricos

Similar Documents

Publication Publication Date Title
JP2010539188A5 (https=)
JP2010539187A5 (https=)
JP2010539186A5 (https=)
HRP20110632T1 (hr) N-fenil-diokso-hidropirimidini korisni kao inhibitori virusa hepatitisa c (hcv)
RU2013104270A (ru) Производные урацила или тимина для лечения гепатита с
RU2014147354A (ru) Пиримидины, которые могут быть использованы в качестве противоинфекционных средств, и их применения
RU2015144653A (ru) Противовирусные соединения и их применения
JP2010510242A5 (https=)
JP2015526441A5 (https=)
JP2010534654A5 (https=)
JP2017511794A5 (https=)
JP2013530240A5 (https=)
JP2009046489A (ja) C−グリコシド誘導体又はその塩
JP2004532227A5 (https=)
JP2008502614A5 (https=)
CA2570942A1 (en) Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicament
JP2013505949A5 (https=)
JP2005514432A5 (https=)
WO2007002637B1 (en) N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
JP2007532654A5 (https=)
AU2014280939B2 (en) Uracil or thymine derivative for treating hepatitis C
JP2014500252A5 (https=)
HK1182090A (en) N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors
HK1145839B (en) N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors